Skip to main content
Clinical Trials/NCT02061579
NCT02061579
Completed
N/A

Initiate and Maintain Physical Activity in Clinics: The IMPACT Diabetes Study

Stanford University1 site in 1 country354 target enrollmentOctober 2016

Overview

Phase
N/A
Intervention
Not specified
Conditions
Diabetes Mellitus
Sponsor
Stanford University
Enrollment
354
Locations
1
Primary Endpoint
Changes in Hemoglobin A1c Level Across Study Visits
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The Initiate and Maintain Physical Activity in Clinics (IMPACT) study will determine the optimal and feasible level of frequency of structured contact needed in a clinical setting for adult patients with Type 2 Diabetes Mellitus to initiate and maintain physical activity recommendations long-term.

Detailed Description

The IMPACT Study will compare the health outcomes and lifestyle habits amongst the three groups of study participants. Study participants will be randomized into three exercise group. Group 1 will participate in instructor-led exercise training sessions 1 time per week, for 24 weeks (approximately 6 months). Group 2 will participate in instructor-led exercise training sessions 3 times per week, for 24 weeks (approximately 6 months). Group 3 will not attend any instructor-led exercise training sessions. All groups will be encouraged to see their usual providers for routine healthcare, and continue their usual medication regimen.

Registry
clinicaltrials.gov
Start Date
October 2016
End Date
January 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Latha Palaniappan, MD, MS

Principal Investigator

Stanford University

Eligibility Criteria

Inclusion Criteria

  • Recent hemoglobin A1c result between 6.5 and 13.0%
  • Diagnosed with Type 2 Diabetes Mellitus
  • Able and willing to enroll and meet the requirements of the study

Exclusion Criteria

  • Inability to speak, read or understand English
  • Long-term current use or dependency on insulin
  • Systolic blood pressure \>180 mm Hg or diastolic blood pressure \>100 mm Hg
  • Resting heart rate \> 120 bpm
  • History of or present heart or cardiovascular conditions
  • History of or present respiratory disease
  • History of or present spinal cord injury
  • History of stroke or Transient Ischemic Attack (TIA)
  • History of cancer diagnosis in the past 5 years or present cancer diagnosis
  • Medical, psychiatric, behavioral limitations that may interfere with study participation

Outcomes

Primary Outcomes

Changes in Hemoglobin A1c Level Across Study Visits

Time Frame: Baseline, 3-, 6-, 18-, 24-, 30-month follow-up

Changes in Maximal Oxygen Consumption Across Study Visits

Time Frame: Baseline, 3-, 6-, 18-, 24-, 30-month follow-up

Changes in Self-Reported Physical Activity Level Across Study Visits

Time Frame: Baseline, 3-, 6-, 18-, 24-, 30-month follow-up

Secondary Outcomes

  • Changes in Self-Reported Quality of Life Across Study Visits(Baseline, 3-, 6-, 18-, 24-, 30-month follow-up)
  • Changes in Body Mass Index Across Study Visits(Baseline, 3-, 6-, 18-, 24-, 30-month follow-up)
  • Changes in Blood Pressure Across Study Visits(Baseline, 3-, 6-, 18-, 24-, 30-month follow-up)
  • Changes in Heart Rate Across Study Visits(Baseline, 3-, 6-, 18-, 24-, 30-month follow-up)
  • Changes in Waist Circumference Across Study Visits(Baseline, 3-, 6-, 18-, 24-, 30-month follow-up)
  • Changes in Body Weight Across Study Visits(Baseline, 3-, 6-, 18-, 24-, 30-month follow-up)
  • Changes in Exercise Perception Across Study Visits(Baseline, 6-, 30-month follow-up)
  • Changes in Patient Satisfaction During Intervention Period(3-, 6-month follow-up)
  • Changes in Dietary Intake Across Study Visits(Baseline, 3-, 6-, 18-, 24-, 30-month follow-up)

Study Sites (1)

Loading locations...

Similar Trials